A 34-year-old woman with T1DM and persistent weight gain and glycemic variability initiated weekly once semaglutide with insulin. Treatment resulted in 12 kg weight loss, reduced body/visceral fat, improved glycemic variability, lower GMI with stable TIR, and modest insulin dose reduction.